LLMpediaThe first transparent, open encyclopedia generated by LLMs

Patent and Trademark Office (United States)

Generated by GPT-5-mini
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: GV Hop 4
Expansion Funnel Raw 70 → Dedup 0 → NER 0 → Enqueued 0
1. Extracted70
2. After dedup0 (None)
3. After NER0 ()
4. Enqueued0 ()
Patent and Trademark Office (United States)
NamePatent and Trademark Office (United States)
Formed1790
JurisdictionUnited States
HeadquartersAlexandria, Virginia
Parent agencyDepartment of Commerce

Patent and Trademark Office (United States) is the federal agency responsible for granting patents and registering trademarks in the United States, administering intellectual property rights established under the Constitution of the United States and statutes such as the Patent Act and the Lanham Act. It operates within the United States Department of Commerce and interfaces with domestic entities including the United States Court of Appeals for the Federal Circuit, the United States District Court for the Eastern District of Virginia, and international bodies such as the World Intellectual Property Organization and the World Trade Organization.

History

The agency traces institutional origins to patent grants issued under the administration of George Washington and statutory authorization in the Patent Act of 1790, evolving through reforms under presidents including Thomas Jefferson and Abraham Lincoln as industrialization and cases like O'Reilly v. Morse shaped doctrine, while landmark statutes such as the Patent Act of 1952 and decisions by the Supreme Court of the United States in matters like Graham v. John Deere Co. influenced examination standards; expansion of trademark registration followed developments under the Lanham Act and enforcement trends under administrations like Franklin D. Roosevelt and Richard Nixon. The agency relocated administrative centers over time from Washington, D.C. to facilities in Alexandria, Virginia and adapted procedures in response to technological change exemplified by inventions associated with Samuel Morse, Thomas Edison, and later firms such as IBM and Bell Telephone Company; international harmonization arose from agreements including the Paris Convention for the Protection of Industrial Property and the Patent Cooperation Treaty. Major institutional shifts include the creation of the Patent Trial and Appeal Board and interplays with reforms debated in Congress alongside cases such as KSR International Co. v. Teleflex Inc. and Alice Corp. v. CLS Bank International.

Organization and Leadership

Organizational structure places the agency under the United States Secretary of Commerce with leadership roles occupied by a Director and executive offices interacting with the Patent Trial and Appeal Board, the Trademark Trial and Appeal Board, and offices such as the Office of Enrollment and Discipline and the Office of the Chief Economist; directors have come from legal and scientific backgrounds similar to leaders associated with Thomas Alva Edison-era patent counsel and advisors to departments like National Institute of Standards and Technology. The agency's divisions coordinate with external institutions including the National Academies of Sciences, Engineering, and Medicine, the Federal Trade Commission, and the Department of Justice on policy, enforcement, and antitrust intersections, while congressional oversight from committees such as the United States Senate Committee on the Judiciary and the United States House Committee on the Judiciary influences nominations and funding.

Patent Examination and Procedures

Patent prosecution at the agency follows statutory frameworks under the Patent Act with procedural steps including filing, examination, search, allowance, and post-grant proceedings such as inter partes review before the Patent Trial and Appeal Board, and appeals to the United States Court of Appeals for the Federal Circuit; practitioners include agents registered through the Office of Enrollment and Discipline and litigants like Apple Inc., Microsoft, and Qualcomm often engage in appeals and enforcement proceedings. Examination standards reference case law from the Supreme Court of the United States and the Federal Circuit including tests from Graham v. John Deere Co., KSR International Co. v. Teleflex Inc., and Alice Corp. v. CLS Bank International for obviousness and patent-eligible subject matter; patent cooperation filings under the Patent Cooperation Treaty permit international phase entry coordinated with national offices such as the European Patent Office and the Japan Patent Office. Administrative mechanisms include priority examinations, petitions, continuations, and fee schedules established by the agency and subject to rulemaking influenced by docket matters involving corporations like Google and research institutions such as the Massachusetts Institute of Technology.

Trademark Examination and Procedures

Trademark practice at the agency is governed by the Lanham Act with processes for application, substantive examination, publication for opposition, registration, and maintenance, and contested disputes resolved at the Trademark Trial and Appeal Board or through federal litigation in courts including the United States District Court for the Southern District of New York and the United States Court of Appeals for the Second Circuit, often involving brands like Coca-Cola, Nike, Inc., and Starbucks. Examination standards evaluate likelihood of confusion, distinctiveness, and descriptiveness referencing precedent from the Supreme Court of the United States and the Federal Circuit and administrative practice shaped by international treaties such as the Madrid Protocol where foreign filers work with national authorities like the Intellectual Property Office (United Kingdom) and the Canadian Intellectual Property Office. Procedural features include oppositions, cancellations, and evidence submission, with enforcement intersecting with customs matters and agencies such as the United States Customs and Border Protection.

Policy, Legislation, and International Relations

Policy development involves coordination with legislative actors in Congress, stakeholders including multinational corporations, academic institutions such as the University of California system, and international negotiations at the World Intellectual Property Organization and the World Trade Organization; major legislative influences include the America Invents Act which altered priority rules and introduced post-grant reviews, shaping interactions with patent offices worldwide including the European Patent Office and the State Intellectual Property Office of the People’s Republic of China. The agency participates in cooperative initiatives like patent prosecution highways with offices such as the Korean Intellectual Property Office and the Australian Patent Office, and responds to economic and technological policy imperatives affecting sectors represented by firms such as Pfizer, Johnson & Johnson, and Tesla, Inc..

Criticisms and Controversies

The agency has faced criticism from academics and litigants including scholars at institutions like Stanford University and Harvard University concerning patent quality, backlogs, and standards for subject matter eligibility after decisions like Alice Corp. v. CLS Bank International, while industry parties such as patent assertion entities and corporations including Samsung and Intel Corporation have disputed examination outcomes and enforcement; controversies involve debates over fee diversion, asserted in hearings before committees like the United States Senate Committee on the Judiciary, and the balance between innovation incentives and antitrust concerns raised by the Federal Trade Commission. Disputes over patentability in fields such as biotechnology implicate cases like Association for Molecular Pathology v. Myriad Genetics, Inc. and policy debates involving research universities, pharmaceutical companies, and public-interest groups.

Category:United States federal agencies